These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 411847)

  • 21. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fundamental and clinical studies of S-6437 in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Yoshioka N
    Jpn J Antibiot; 1977 Sep; 30(9):729-37. PubMed ID: 916194
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies with cefadroxil for urinary tract infections (author's transl)].
    Ikegaki S; Nishio A; Ohno K; Kumamoto Y; Terada M
    Jpn J Antibiot; 1980 Mar; 33(3):371-4. PubMed ID: 7401312
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newer antibiotic agents acting on gram-negative organisms.
    Hill HR; Matsen JM
    Geriatrics; 1973 Aug; 28(8):72-6. PubMed ID: 4212199
    [No Abstract]   [Full Text] [Related]  

  • 29. [Resistance to rifampicin. In vitro and in vivo studies].
    Bouanchaud DH; Acar JF
    Pathol Biol (Paris); 1969; 17(15):763-7. PubMed ID: 4907911
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experience with cefadroxil (author's transl)].
    Izawa A
    Jpn J Antibiot; 1980 Mar; 33(3):361-6. PubMed ID: 7401310
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions].
    Kobayashi Y; Akaishi K; Nishio T; Goto K; Aihara M
    Jpn J Antibiot; 1972 Apr; 25(2):104-19. PubMed ID: 4561052
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.
    Boyer JL; Andriole VT
    Yale J Biol Med; 1968 Feb; 40(4):284-95. PubMed ID: 4870320
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical application of rifampicin to common infections (author's transl)].
    Nakagawa K; Watanabe K; Suzuki T
    Jpn J Antibiot; 1974 Apr; 27(2):69-72. PubMed ID: 4603394
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with gentamicin in complicated urinary tract infections (author's transl)].
    Fujimura N; Fukukawa T
    Jpn J Antibiot; 1976 Mar; 29(3):303-8. PubMed ID: 775144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of urinary tract infections in children. Clinical experience with minocycline granules (author's transl)].
    Hiraumi M; Tani J; Okamoto Y; Tada K
    Jpn J Antibiot; 1974 Dec; 27(6):730-4. PubMed ID: 4219032
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of S-6437 in pediatrics regarding clinical efficacy, blood levels and urinary excretion (author's transl)].
    Nanri S; Sunagawa K; Hara N; Kimura K; Osano M
    Jpn J Antibiot; 1977 Sep; 30(9):699-709. PubMed ID: 916191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of BL-S217, a new cephalosporin antibiotic.
    Casey F; Bodey GP
    J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
    [No Abstract]   [Full Text] [Related]  

  • 38. [The basic studies on chemotherapy in urinary tract infection due to organisms with resistance to antibiotics (author's transl)].
    Igari J
    Jpn J Antibiot; 1977 Aug; 30(8):596-611. PubMed ID: 409865
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of urinary tract infections with amikacin (BB-K8) (author's transl)].
    Hirokawa I; Nakano I; Okada K; Higaki M; Akima S
    Jpn J Antibiot; 1974 Apr; 27(2):193-201. PubMed ID: 4603934
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)].
    Okita K; Sato M; Hayakawa K; Kimura K
    Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.